Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Antibe Therapeutics Inc (ATE.VN)

Antibe Therapeutics Inc (ATE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 148,403
  • Shares Outstanding, K 385,462
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.82
Trade ATE.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.08
  • Most Recent Earnings $-0.02 on N/A
  • Latest Earnings Date 11/26/20
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.01
  • Number of Estimates 2
  • High Estimate -0.01
  • Low Estimate -0.02
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.305 +32.79%
on 10/29/20
0.410 -1.22%
on 11/11/20
+0.055 (+15.71%)
since 10/09/20
3-Month
0.305 +32.79%
on 10/29/20
0.430 -5.81%
on 08/24/20
-0.015 (-3.57%)
since 08/11/20
52-Week
0.305 +32.79%
on 10/29/20
0.890 -54.49%
on 06/01/20
-0.030 (-6.90%)
since 11/11/19

Most Recent Stories

More News
BioMedNewsBreaks – Antibe Therapeutics Inc. (TSXV: ATE) (OTCQB: ATBPF) Graduates to the TSX

Antibe Therapeutics (TSXV: ATE) (OTCQB: ATBPF), a clinical stage company leveraging its unique hydrogen sulfide platform to develop safer medicines for pain and inflammation, today announced its receipt...

ATE.VN : 0.405 (+5.19%)
ATBPF : 0.2156 (+13.47%)
LD Micro - 360 Companies Set to Present this Week

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online....

ACEYY : 7.6400 (+48.35%)
ISDR : 11.65 (-1.69%)
PLL.AX : 0.180 (unch)
ACER : 0.6601 (-17.95%)
ACRX : 0.8600 (+7.50%)
ACU : 40.46 (+1.02%)
ADIL : 1.7000 (-10.53%)
ADTX : 2.27 (+2.25%)
ADXS : 0.5400 (-5.59%)
AEHR : 10.56 (-0.28%)
AERG : 1.9100 (-1.04%)
AEY : 0.3600 (-40.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Antibe Therapeutics Inc develops safer, non-addictive medicines for pain and inflammation. Its technology involves linking a hydrogen sulfide-releasing molecule to an existing drug to produce an improved and patented medicine. The company's drug, ATB-346, targets the global need for a safer, non-addictive...

See More

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.425
1st Resistance Point 0.415
Last Price 0.405
1st Support Level 0.390
2nd Support Level 0.375
3rd Support Level N/A

See More

52-Week High 0.890
Fibonacci 61.8% 0.667
Fibonacci 50% 0.597
Fibonacci 38.2% 0.528
Last Price 0.405
52-Week Low 0.305

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar